Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2015 10:02 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Launch of Generic Hydroxyzine Tablets

NORTHVALE, N.J., April 21, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) today announced the launch of generic Hydroxyzine HCI 10 mg, 25 mg and 50 mg...
February 17, 2015 17:56 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2015

Revenues Increase 8.5% Over Prior Quarter Conference Call Scheduled for Wednesday, February 18 at 11:00 AM EST NORTHVALE, N.J., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc....
February 17, 2015 17:55 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Provides Guidance on Phase III Study for ELI-200

NORTHVALE, N.J., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced guidance today regarding the Company's Phase III trial for ELI-200, an...
February 12, 2015 14:49 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, February 18, 2015

NORTHVALE, N.J., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
January 15, 2015 10:46 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules

NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
December 16, 2014 08:38 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation

NORTHVALE, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the continued expansion of Elite's intellectual property...
December 03, 2014 09:55 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse-Deterrent Oxycodone Product ELI-201

NORTHVALE, N.J., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today successful results from a pivotal bioequivalence (BE) study for...
November 18, 2014 18:24 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015

Revenues increase by 8% Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST NORTHVALE, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the...
November 13, 2014 17:02 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, November 19, 2014

NORTHVALE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
October 24, 2014 07:15 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces New Management Appointments

NORTHVALE, N.J., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP),a specialty pharmaceutical company developing a pipeline of abuse-deterrent...